Search details
1.
MGuard mesh-covered stent for treatment of ST-segment elevation myocardial infarction with high thrombus burden despite manual aspiration.
J Interv Cardiol
; 26(1): 1-7, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23419104
2.
Revascularized ST-segment elevation myocardial infarction. Temporal trends in contemporary therapies and impact on outcomes.
Rev Esp Cardiol (Engl Ed)
; 75(8): 659-668, 2022 Aug.
Article
in English, Spanish
| MEDLINE | ID: mdl-34887210
3.
Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain).
BMJ Open
; 9(7): e028114, 2019 07 23.
Article
in English
| MEDLINE | ID: mdl-31340964
4.
Preserved endothelial vasomotor function after everolimus-eluting stent implantation.
EuroIntervention
; 11(6): 643-9, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-25022229
5.
Lumen enlargement of the coronary segments located distal to chronic total occlusions successfully treated with drug-eluting stents at follow-up.
EuroIntervention
; 9(10): 1181-8, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24561735
6.
Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation.
J Cardiovasc Transl Res
; 7(1): 39-46, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24362676
7.
Clopidogrel pretreatment in primary percutaneous coronary intervention: prevalence of high on-treatment platelet reactivity and impact on preprocedural patency of the infarct-related artery.
Thromb Haemost
; 110(1): 110-7, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23615769
8.
Global risk score for choosing the best revascularization strategy in patients with unprotected left main stenosis.
J Invasive Cardiol
; 25(12): 650-8, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24296385
9.
Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
Rev Esp Cardiol (Engl Ed)
; 65(6): 530-7, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22521483
10.
Impact on delay times and characteristics of patients undergoing primary percutaneous coronary intervention in the southern metropolitan area of Barcelona after implementation of the infarction code program.
Rev Esp Cardiol (Engl Ed)
; 65(10): 911-8, 2012 Oct.
Article
in English, Spanish
| MEDLINE | ID: mdl-22868183
11.
[Superiority of levosimendan to dobutamine in postoperative low cardiac output syndrome: is it due to previous beta-blocker treatment?]. / Superioridad del levosimendán comparado con dobutamina en el síndrome de bajo gasto cardiaco postoperatorio. Se debe al tratamiento previo con bloqueadores beta?
Rev Esp Cardiol
; 61(11): 1225; author reply 1225-6, 2008 Nov.
Article
in Spanish
| MEDLINE | ID: mdl-19000504
12.
Impacto en tiempos de actuación y perfil de los pacientes tratados con angioplastia primaria en el área metropolitana sur de Barcelona al implantar el programa Código Infarto / Impact on delay times and characteristics of patients undergoing primary percutaneous coronary intervention in the southern metropolitan area of Barcelona after implementation of the infarction code program
Rev. esp. cardiol. (Ed. impr.)
; 65(10): 911-918, oct. 2012. tab, ilus
Article
in Spanish
| IBECS (Spain) | ID: ibc-103676
13.
Seguimiento a largo plazo tras el tratamiento percutáneo del tronco coronario izquierdo no protegido en pacientes de alto riesgo no aptos para cirugía de revascularización / Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery
Rev. esp. cardiol. (Ed. impr.)
; 65(6): 530-537, jun. 2012. tab, ilus
Article
in Spanish
| IBECS (Spain) | ID: ibc-100254
14.
Superioridad del levosimendán comparado con dobutamina en el síndrome de bajo gasto cardiaco postoperatorio. ¿Se debe al tratamiento previo con bloqueadores beta? / Superiority of levosimendan to dobutamine in postoperative low cardiac output syndrome: is it due to previous beta-blocker treatment?
Rev. esp. cardiol. (Ed. impr.)
; 61(11): 1225-1225, nov. 2008.
Article
in Es
| IBECS (Spain) | ID: ibc-70679
Results
1 -
14
de 14
1
Next >
>>